Eton Pharmaceuticals Inc.
(ETON)
undefined
undefined%
At close: undefined
12.35
0.32%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 31.64M | 21.25M | 21.83M | 39.00K | 959.00K | - | - |
| Cost of Revenue | 10.58M | 6.93M | 2.62M | 286.00K | 453.00K | 63.00K | 13.00K |
| Gross Profit | 21.06M | 14.32M | 19.21M | -247.00K | 506.00K | -63.00K | -13.00K |
| Operating Income | -1.19M | -8.26M | -1.50M | -27.11M | -18.60M | -10.32M | -7.15M |
| Interest Income | - | 761.00K | 1.01M | 859.00K | 281.00K | 164.00K | 52.50K |
| Pretax Income | -689.00K | -9.02M | -1.96M | -27.97M | -18.32M | -12.74M | -7.16M |
| Net Income | -936.00K | -9.78M | -2.96M | -28.83M | -18.04M | -12.74M | -7.16M |
| Selling & General & Admin | 18.93M | 18.58M | 14.47M | 12.76M | 7.55M | 4.69M | 3.21M |
| Research & Development | 3.32M | 4.00M | 6.24M | 14.10M | 11.55M | 5.63M | 3.93M |
| Other Expenses | - | - | - | - | - | - | - |
| Operating Expenses | 22.25M | 22.58M | 20.70M | 26.86M | 19.11M | 10.32M | 7.14M |
| Interest Expense | - | 955.00K | 1.01M | 889.00K | - | - | - |
| Selling & Marketing Expenses | - | - | - | - | - | - | -1.62M |
| Cost & Expenses | 32.83M | 29.51M | 23.33M | 27.15M | 19.56M | 10.32M | 7.15M |
| Income Tax | 247.00K | 761.00K | 1.01M | 859.00K | -281.00K | -2.58M | - |
| Shares Outstanding (Basic) | 25.64M | 25.15M | 25.21M | 21.01M | 17.76M | 6.42M | 17.46M |
| Shares Outstanding (Diluted) | 25.65M | 25.15M | 25.21M | 21.01M | 17.76M | 6.42M | 17.46M |
| EPS (Basic) | -0.04 | -0.39 | -0.12 | -1.37 | -1.02 | -1.99 | -0.41 |
| EPS (Diluted) | -0.04 | -0.39 | -0.12 | -1.37 | -1.02 | -1.99 | -0.41 |
| EBITDA | -291.00K | -6.49M | -1.12M | -26.46M | -18.15M | -10.26M | -7.14M |
| Depreciation & Amortization | 901.00K | 1.76M | 447.00K | 651.00K | 447.00K | 63.00K | 13.00K |